Kim Kjoller

Company: UNION Therapeutics

Job title: Chief Executive Officer

Seminars:

Overcoming the Moderate Efficacy Conundrum in PDE4 Inhibition through Hidradenitis Suppurativa 11:30 am

Outlining PDE4i mode of action and the therapeutic potential to treat across numerous indications with serious unmet need Identifying subtypes to target B & D specificity in candidate compound Championing an oral delivery method with a good safety profile drug candidateRead more

day: Day 2 AM - Track B

Panel Discussion: Exploring the Dermatology Financing Landscape for 2022 & Beyond 8:00 am

What are large pharma looking for when partnering & how can smaller biotechs best prepare to partner How & where do you begin with developing a candidate for the rare disease space Debating how to position your drug candidate in the market where patients have failed other trialsRead more

day: Day One